Showing 1,098 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

Copy of Reyataz May Be Safe for HIV-Positive People With Severe Liver Disease

Editor's pick
Kaiser Daily Global Health Policy Report
24 March 2011
Hepatitis C treatment

Reyataz May Be Safe for HIV-Positive People With Severe Liver Disease

Editor's pick
AIDSMeds
24 March 2011
New & experimental hepatitis C treatment

Next Stage for Biotron's Hep C Drug

Editor's pick
Hepatitis Central
23 March 2011
Hepatitis C treatment

More Support for Genetic Testing of Hepatitis C Patients

Editor's pick
Internal Medicine News
16 March 2011
New & experimental hepatitis C treatment

Telaprevir, Boceprevir for Hep C Approaching FDA Finish Line

Editor's pick
Poz
16 March 2011
New & experimental hepatitis C treatment

Copy of Telaprevir, Boceprevir for Hep C Approaching FDA Finish Line

Editor's pick
Poz
16 March 2011
Hepatitis C treatment

iTherX Initiates Phase 1b Study of First-in-Class Hepatitis C Virus Entry Inhibitor ITX-5061

Editor's pick
PR Newswire
15 March 2011
New & experimental hepatitis C treatment

Who will win the hepatitis C market?

Editor's pick
Seeking Alpha
15 March 2011
Hepatitis C treatment

FDA Panel To Review Merck, Vertex Hepatitis Drugs In Late April

Editor's pick
Wall Street Journal
15 March 2011
Hepatitis C transmission & prevention

High rate of HCV reinfection after treatment of acute infection in Amsterdam gay men

News
10 March 2011
New & experimental hepatitis C treatment

The Hepatitis C Pipeline Report

Editor's pick
Treatment Action Group
9 March 2011
Hepatitis C treatment

Pharmasset Hep C Data Wows Investors

Editor's pick
The Street
9 March 2011
New & experimental hepatitis C treatment

Telaprevir works well for people with HIV/HCV co-infection

News
2 March 2011
Hepatitis C treatment

Lack of health insurance limits hepatitis C patients' access to latest antiviral therapy

Editor's pick
Eurekalert Inf Dis
24 February 2011
Hepatitis C treatment

Medivir Announces Positive Phase 2b 48-week (SVR24) Interim Results of TMC435 in Treatment-Naive Patients Chronically Infected With Genotype-1 Hepatitis C Virus

Editor's pick
PR Newswire
22 February 2011
Hepatitis C treatment

Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 In Adults With Chronic Genotype 1 HCV

Editor's pick
Medical News Today
22 February 2011
Pharmaceutical industry

Idenix drops after FDA loosens one hold but slaps on another

Editor's pick
Fierce Biotech
10 February 2011
Hepatitis C treatment

Warning issued to Fuzeon, Pegasys, Viraferon Peg and Intron A users

News
9 February 2011
Hepatitis C symptoms & diagnosis

Vertex urges CDC to recommend hep C screening, to nudge `second tsunami` of patients

Editor's pick
EATG
3 February 2011
Hepatitis C treatment

Hep C Treatment Telaprevir Gets Fast-Tracked FDA Review

Editor's pick
AIDSMeds
21 January 2011
Hepatitis C treatment

Copy of Hep C Treatment Telaprevir Gets Fast-Tracked FDA Review

Editor's pick
Kaiser Daily Global Health Policy Report
21 January 2011
People with limited treatment options

Manufacturer Recalls Alcohol Swab Products Packaged with Fuzeon, Other Meds

Editor's pick
AIDSmeds
20 January 2011
Hepatitis C symptoms & diagnosis

New drugs take aim at hepatitis C, spur debate on whether to test baby boomers

Editor's pick
Canadian Press
18 January 2011
Hepatitis C treatment

Bristol-Myers Squibb and Pharmasset Enter into a Clinical Collaboration Agreement for Proof of Concept Combination Study in Patients Chronically Infected with Hepatitis C

Editor's pick
Business Wire
10 January 2011